Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Current Opinion in Organ Transplantation|January 31, 2016
Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and moreAvash Kalra, Joel P Wedd, Scott W Biggins
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 13, 2015
Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patientJoel P Wedd, Eric Nordstrom, Trevor Nydam, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 23, 2016
Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosisAvash Kalra, Joel P Wedd, Kiran M Bambha, et al.
Chinese Clinical Oncology|June 13, 2020
The optimal timing and management of hepatitis B and C in patients with hepatocellular carcinomaThuy-Van P Hang, Joel P Wedd
Seminars in Liver Disease|July 20, 2006
MELD-based liver allocation: who is underserved?Scott W Biggins, Kiran Bambha
Current Opinion in Organ Transplantation|December 5, 2020
Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving processMichael Kriss, Scott W Biggins
Current Opinion in Gastroenterology|February 22, 2018
New paradigms for organ allocation and distribution in liver transplantationAvash Kalra, Scott W Biggins
Clinics in Liver Disease|July 19, 2005
Treatment of recurrent hepatitis C after liver transplantationScott W Biggins, Norah A Terrault
Infectious Disease Clinics of North America|March 11, 2006
Management of recurrent hepatitis C in liver transplant recipientsScott W Biggins, Norah A Terrault
Current Opinion in Organ Transplantation|August 8, 2008
Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additionsKiran M Bambha, Scott W Biggins
Pageof 14